SlideShare a Scribd company logo
Seminar on ……

ISO series, guide of pharmaceutical
manufacturing facilities, productivity


                  By :
                 Mr. Kailash Vilegave.
                 Assit prof.
                 Shivajirao S Jondhle college of
                   pharmacy Asangaon 421601

                  Department of Pharmaceutics   9/2/2012   1
Contents

 Introduction.
 History.
 ISO: 9000 series.
 ISO:14000 series.
 Guide to Pharmaceutical Manufacturing
  Facilities, Productivity.
 References.


                        Department of Pharmaceutics   9/2/2012   2
Introduction
    What are ISO 9000 Standards?

 ISO 9000 Standards
   Define the required elements of an effective quality
    management system
   Can be applied to any company
   Adopted by the United States as the ANSI/ASQC Q90
    series.

    STANDARD BODIES
    154 COUNTRIES
    Bureau of Standards Jamaica


                             Department of Pharmaceutics   9/2/2012   3
Background Who Created Standards

• ISO WAS FORMED FEBRUARY 23, 1947 IN
  GENEVA
• FIRST FAMILY OF QUALITY STANDARD
  RELEASED 1987
   – To eliminate country to country differences
   – To eliminate terminology confusion
   – To increase quality awareness
• FIRST ENVIRONMENTAL STANDARD
  RELEASED IN 1996

                         Department of Pharmaceutics   9/2/2012   4
How did ISO get started?

          1906 - International Electro-technical Commission
    1926 - International Federation of the National Standardizing
                          Associations (ISA)


 1946 London - delegates from 25 countries decided to create a new
international organization "the object of which would be to facilitate the
    international coordination and unification of industrial standards

                 1947 - ISO began to officially function
              1951 - The first ISO standard was published
            "Standard reference temperature for industrial length
                              measurement".


                                      Department of Pharmaceutics   9/2/2012   5
ISO 9000 Consists of 5
       Documents
 ISO 9000 Quality Management and Quality Assurance Standards


ISO 9001 Quality Systems - QA Model for Design/Development,
Production, Installation, and Service

ISO 9002 Quality Systems - QA Model for Production and Installation (no
design)

ISO 9003 Quality Systems - QA Model for Final Inspection and Test

ISO 9004 Quality Management and Quality System Elements -
Guidelines


                                   Department of Pharmaceutics   9/2/2012   6
ISO 9000 Family of Standards
•ISO 9000-2 - Generic guidelines for applying ISO 9001, ISO 9002, and
                              •ISO 9003

         ISO 9000-3 - Guidelines for applying ISO 9001 to the
          development, supply, and maintenance of software

        ISO 9000-4 Application for dependability management

                 ISO 9004-2 Guidelines for services
            ISO 9004-3 Guidelines for processed material
            ISO 9004-4 Guidelines for quality improvement
                ISO 9004-5 Guidelines for quality plans

   •ISO 9004-6,7- Guidelines for project & configuration management

                                   Department of Pharmaceutics   9/2/2012   7
What has ISO Accomplished?
• ISO film speed code
• TL9000 Standard format for telephone and banking cards
• ISO 9000 which provides a framework for quality
  management and quality assurance
• ISO 14000 series provides a similar framework for
  environmental management
• Internationally standardized freight containers
• Standardized paper sizes.
• Automobile control symbols
• ISO international codes for country names, currencies
  and languages
• AS 9100 the Aerospace Basic Quality System Standard

                           Department of Pharmaceutics   9/2/2012   8
ISO 9000:1987 series                  ISO 9000:1994 series

  International Organisation           ISO 9000 was revised in
for Standards (ISO) adopted                    1994
       a series of quality
 standards, ISO 9000:1987           greater emphasis on quality
                                     assurance via preventive
     based on BS5750                          actions.
strongly influenced by the               required evidence of
US Department of Defence                   compliance with
    Military Standards                 documented procedures
       (MILspecs).
                                         tended to create a
 initial version was focused           significant volume of
   on quality control using            associated procedure
     retroactive checking           ("do it as you document it")
   and corrective actions.          manuals and bureaucracy.
                               Department of Pharmaceutics   9/2/2012   9
QS-9000                         ISO9000:2000 series

 Ford, Chrysler, General
                                           2nd revision of Quality
    Motors and other
                                           Management System
    automotive/truck                    Requirement Standard from
 manufacturers identified              International Organization for
     deficiencies in                             Standards
     ISO9000:1994
                                             moved towards
      undertook a re-                  process performance metrics
    interpretation and                     reduced the need for
extension to develop QS-                 documented procedures
           9000                         where clear evidence exists
                                        that the process is working
  additionally addressed
                                                    well.
        continuous
improvement, manufacturin             Replacement for previous ISO
g capability and production              9001 / 9002 and 9003
 part approval processes.                  standards of 1994
                              Department of Pharmaceutics   9/2/2012    10
ISO9000:2000                                      Future
series                                         Version : 2008
 standards provide criteria for
  companies to                               TC 176, the ISO 9001
 "certify" their quality
                                              technical committee
  management
                                              , has started its review on
                                              the next version of ISO
   recertification is required               9001, which will in all
     every three years                        likelihood be termed the
 achieve "registration" by third-            ISO 9001:2008
  party auditor.                              standard, assuming its
                                              planned release date of
 the system                                  2008 is met. Early reports
   verifies practice and                     are that the standard will
     processes                                not be substantially
   provides objective 3rd
                                              changed from its 2000
                                              version.
     party validation
   enables benchmarking.



                                     Department of Pharmaceutics   9/2/2012   11
New ISO 9001



                            Management
                         Responsibility


                                           Measurement,
   General      Resource                     analysis &    General
requirements   management      QMS
                                           improvements requirements



                              Product
                             Realization



                   Continual Improvement cycle
                                 Department of Pharmaceutics   9/2/2012   12
ISO 9001: Model
                         Continual Improvement of
                      the Quality Management System



                           5.Management
                           Responsibility




                                                                                          CUSTOMERS
    CUSTOMERS




                          Quality Management




                                                                           Satisfaction
                6. Resource              8. Measurement
                                            Analysis and
                Management                  Improvement

                               System


                             7. Product
Requirements                                            Product               Consumption
                             Realization
                                  Department of Pharmaceutics   9/2/2012                        13
Principle Of New Standards

                   Customer
                    focus
     Mutual
   beneficial
    supplier
  relationshi          Based on eight
       p                  quality
                        management
   Factual
                         principles
  approach
     to
  decision
   making                           System
                 Continual         approach
                improveme             to
                    nt             Manageme
                                      nt
                              Department of Pharmaceutics   9/2/2012   14
Principles of new standard
                       Customer focus
      •Organization depends customers
      •Understand current & future customer needs.
      •Meet / exceed customer expectations


                          Leadership
      •Leaders establish purpose & direction of the organization
      •Should create & maintain environment to achieve
      organization’s objectives


                   Involvement of People
      •People of all levels are essence of an organization
      •Their full involvement for organization’s benefit


                     Process approach
    Desired results are achieved more efficiently when activities and
                  resources are managed as process

                                 Department of Pharmaceutics   9/2/2012   15
Principles of new standard
                System approach to Management
    Identifying, understanding and managing interrelated process as a
     system contributes to the organization’s effectiveness & efficiency



                     Continual improvements
     Continual improvement of the organization’s overall performance
           should be a permanent objective of the organization




          Factual approach to decision making
   Effective decisions are based on the analysis of data and information



       Mutually beneficial supplier relationships
       •An organization & its suppliers are interdependent
       •Mutually beneficial relationship enhances the ability of both to
       create value
                                  Department of Pharmaceutics   9/2/2012   16
Expectations of the new
Standard
 Avoid the application of systems that are separate from the
 organization’s business process


 Enable the development of a Quality system that is fully
 integrated into the normal operations of organization’s business


 Enable Continual improvements of the system for enhanced
 customer satisfaction



 Enable compliance to statutory & regulatory requirements




                                  Department of Pharmaceutics   9/2/2012   17
Important changes

Criteria               Previous version                        New Version
Main focus             Products                                Customer satisfaction

Approach               20 quality elements                     Value adding processes

Product requirements   Requirements specified by               + Statutory & regulatory
                       customer / organization                 requirements

Involvement of         What to do, When, Whom & How + Why it is to be done
people                 to do

Improvements           Maintain the system                     Continual improvements
                       requirements                            should be achieved




                                         Department of Pharmaceutics   9/2/2012           18
Process approach
                             Process definition
            Set of interrelated or interacting activities which transforms
                                 inputs into outputs



                                 Identify the                                      Ensure
 Identify        Identify                               Establish
                                 Interaction                                      continual
   the          the Inputs                              measurin
                                  s to other                                    improvemen
processes       & outputs                               g criteria
                                  processes                                          ts




                Do it for all value adding processes

                                       Department of Pharmaceutics   9/2/2012             19
Process approach –
Continual improvements of Process

                      Understandings &
                     meeting requirements
                            PLAN



                                                    Continual improvements
Processes in terms
                                                     of Processes based on
  Of Added Value          PDCA Cycle
                                                    objective measurements
       DO
                                                            ACTION



                   Measure results of process
                 Performance and effectiveness
                   - Objective Measurements
                             CHECK
                               Department of Pharmaceutics   9/2/2012    20
System Requirements / Structure of the
Standard
 4 Quality         5 ISO9000            6 ISO9000               7 ISO9000             8 ISO9000
 Manageme          structure I          structure II            structure             structure
 nt System         Management           Resource                III Product           IV
                   Responsibility       Management              Realization           Measureme
                                                                                      nt Analysis
   General            Management         Provision of                                 &improveme
                                                                   Planning
   requirements       Commitment         resources                                    nt

                                                                   Customer            General
   Documentation      Customer focus     Human
   Requirements                          resources                 related
                                                                   processes
                                                                                       Monitoring &
                      Quality policy     Infrastructures                               measurement
                                                                   Design &
                                                                   development
                                                                                       Control of NCP
                      Planning           Work
                                         environment               Purchasing
                                                                                       Analysis of data
                      Responsibility,
                      authority &                                  Production &
                      communication                                service             Improvements
                                                                   provision

                      Management
                      Reviews
                                             Department of Pharmaceutics   9/2/2012                       21
4 - Quality management system

                                  Identification
        Continual                 of processes
        improvements               required



                    4.1 General
                                                  Criteria and
                    requirements
   Monitoring and                            methods to ensure
    Measuring of                             Operation & control
     processes
                       Availability of
                       information &
                       resources for
                    operation & control

                           Department of Pharmaceutics   9/2/2012   22
4 - Quality management system

              4.2 Document requirements


                     Quality Policy


                   Quality Objectives


                     Quality Manual


          Procedures required by the Standard

       Procedures required for planning, operation
           & control of Organization activities

                        Records
                            Department of Pharmaceutics   9/2/2012   23
5 - Management Responsibility


5.1          5.2        5.3        5.4                 5.6                  5.7
Management   Customer   Quality    Planning            Responsibility       Management
commitment   focus      policy                         authority &          Review
                                                       communicate



                                  Quality              Responsibility        General
                                  objectives           & authority
                                                                             Review
                                  QMS                  Management            inputs
                                  planning             representative
                                                                             Review
                                                       Internal              outputs
                                                       communication




                                   Department of Pharmaceutics   9/2/2012              24
5 - Management Responsibility

   Development, implementation and
    continually improvement of QMS

                                 Establishment of
                                        •Quality Policy
                                        •Quality Objectives
        Top
    Management’s
                                     Identification of Customer requirements
     commitment

                                     Communication of importance of
•Appointment of Management                  •Regulatory & statutory requirements
 Representative                             •Meeting customer requirements
•Conducting Management                      •Quality Policy & Quality objectives
Reviews                                     •Responsibilities & authorities

•Providing required resources

                                     Department of Pharmaceutics   9/2/2012        25
6 - Resource Management


 6.1              6.2               6.3                                6.4
                                    Infrastructures
 Provision of     Human                                                Work
 resources        Resources                                            Environment


                General

                Competence,
                awareness &
                training




                              Department of Pharmaceutics   9/2/2012                 26
6 - Resource Management

          Resources required to
              Implementing, monitoring & continual
              improvements
              Enhance Customer satisfaction by
              meeting customer requirements

                          Human Resources
 Resource
Managemen
    t                   Infrastructures
                            Infrastructures needed to achieve product
                            conformity


  Work environment
     Work environment needed to achieve product
     conformity

                               Department of Pharmaceutics   9/2/2012   27
6 - Human Resources

      Competent on the basis of appropriate
        education, skill and experience


                          Define competencies for people
                      performing work affecting product quality
    6.2
  Human
                                        Provide training or actions
 Resource
     s
                       Evaluate effectiveness of the training /
                                       actions


    Employees should aware importance of the
            activity being performed

                                 Department of Pharmaceutics   9/2/2012   28
7 - Product Realization


7.1           7.2                 7.3                    7.4                  7.5                 7.6
Planning      Customer            Design and             Purchasing           Production          Control of
of product    related             development                                 & service           monitoring
              processes                                                       provision           measuring
realization                                                                                       devices

              Identification of   Design planning        Purchasing           Control
              customer                                   process
              requirement
                                  Design inputs                                Validation of
                                                         Purchasing            processes
              Review of           Design outputs         information
              customer                                                         Identification &
              requirement                                                      traceability
                                  Design review          Verification of
                                                         purchased
                                                         products
              Customer            Design                                       Customer
              communication       verification                                 property


                                  Design validation                            Preservation of
                                                                               product

                                  Design Changes


                                                      Department of Pharmaceutics   9/2/2012                   29
7 - Product Realization


                 Quality objectives of Products



                            Processes, procedures to realize
                            product
7.1
Planning of
Product
                           Verification, validation, monitoring, ins
realization                pection and testing of product




                   Record to demonstrate conformance



                        Department of Pharmaceutics   9/2/2012         30
7 - Product Realization

                               Identification of Customer / Market
                               requirements
                               •Specified by customer
                               •Requirements taken for granted
7.2                            •Statutory / Regulatory requirements
Customer related
processes –                          Review of requirements related
(Sales)                              product prior to acceptance /
                                     commitment to customers - ability
                                     to meet customer requirements



             Effective communication with customer in relation to
                   •Product information
                   •Sales order handling
                   •Customer feedback
                   •Customer complaints
                                   Department of Pharmaceutics   9/2/2012   31
7 - Product Realization


                                  Planning
                                  •Effective & efficient
                                  •Expectations of interested parties

     7.3
 Design and
Development –
  (Product)                         Design inputs and outputs




       Review and verification, validation and control of changes
       •Accuracy
       •Potential hazards & faults
       •Corrections
       •Evaluations against lessons learnedPharmaceutics 9/2/2012
                                   Department of                        32
7 - Product Realization

                      Degree of control depends on effects of
                      subsequent processes and effect on final
                      product

      7.4
 Purchasing
                                     Supplier evaluation
 Purchasing is done
 in controlled
 manner to ensure
 that purchased
 products conforms
 to specific              Verification of purchased product –
 requirements             Inspection and testing




                          Department of Pharmaceutics   9/2/2012   33
7 - Product Realization

      Product
      characteristics                   Procedures and work instructions


                                           Suitable equipments to manufacture.
7.5
                                           Monitoring and inspection & testing
Production and
service provision                          Product release, delivery and post
Manufacturing /                            delivery
service provision
under controlled                            Process validation
condition to ensure
conformity of product
                                     Identification and
                                     traceability

      Customers property
      Material supplied by customers – e.g.. 3rd party blending
                                         Department of Pharmaceutics   9/2/2012   34
8 - Measurement, analysis
      and improvement
8.1         8.2                 8.3                  8.4                      8.5
                                Control of
General     Monitoring &        non                  Analysis                 Improvement
            measurements        conforming           of data
                                product

              Customer                                                        Continual
              satisfaction                                                    improvements

              Internal audits                                                  Corrective
                                                                               action
              Measurement
              of processes                                                     Preventive
                                                                               action
              Measurement
              of product




                                     Department of Pharmaceutics   9/2/2012                  35
8 - Measurement, analysis
 and improvement
     8.1 - To demonstrate
    • Conformity of the product
    • Conformity to QMS requirements
    • Continually improvements and the effectiveness of the system


   8.2 - Monitoring and Measurements
   •Customer satisfaction / perception
   •Internal audits - conformity planned arrangements of QMS and
     ISO9001
   •Monitoring and measurements of processes – to determine /
   demonstrate ability of processes to achieve required results
   •Monitoring and measurements of product – Conformity to
   product requirements


   8.3 - Control of NCP
   •To assure that NCP products are identified and controlled to
   prevent unintended use / delivery
                                  Department of Pharmaceutics   9/2/2012   36
8 - Measurement, analysis
and improvement

  8.4 - Analysis of data
  Collection and analysis of data generated through QMS
  activities to verify suitability, effectiveness and continual
  improvement of the system


  Analysis shall provide information related to

       •Customer satisfaction / perception
       •Conformity to specs, requirements
       •Trends of processes and products
       • Opportunities for preventive actions
       •Suppliers




                                   Department of Pharmaceutics   9/2/2012   37
8 - Measurement, analysis
   and improvement
                      8.5 - Improvements
Continual Improvements
   •QMS needed to be continually improved


Corrective action
    •Actions to prevent recurrence of NCP, NCR etc
    •Includes reviews, determination of causes, need of action,
     implementation of action, review of action and maintenance
     of relevant records


Preventive action
   •Actions against potential non conformities to avoid their
   occurrence
   •Includes identification of potential non conformities, cause,
    need for action, implementation of action, review of action
    and maintenance of records
                                     Department of Pharmaceutics   9/2/2012   38
Criteria for measurements
–Satisfaction surveys for customers and other interested
 parties
    •Feedback on products
    •Customer & market requirements

                                              –Financial measurements
                                                     •Prevention cost
        System
                                                     •Non conforming / failure cost
      performanc                                     •Lifecycle cost
           e
                                             Self assessment
   –Internal audits
       •Effectiveness & efficiency of processes
       •Opportunities for improvements
       •Use of data / information
       •Effective & efficient use of resources
       •Adequacy, accuracy and performance of measurements
       •Relationships with customers/ suppliers/ other interested
        parties
                                        Department of Pharmaceutics   9/2/2012        39
Criteria for measurements

                                      –Process capability / process validation
   Processe                           –Reaction time
      s                               –Cycle time / throughput (Capacity)
                                      –Utilization of technology
                                      –Waste reduction
                                      –Cost reduction


   Products


    –Inspection and testing of incoming, in process and final
     product
    –Product verification
    –Product validation


                                  Department of Pharmaceutics   9/2/2012    40
What is ISO 14000?
        Primarily concerned with Environmental Management

            Minimize harmful effects on the environment

  Continual Improvement of environmental performance


The formation of ISO Technical Committee 207 (TC 207) in 1993 marks
the beginning of the development of the ISO 14000 series. The US
Technical Advisory Group (TAG) for ISO/TC 207 (US/TAG for ISO/TC
207) represents the United States in international negotiation on ISO
14000


         ISO 14000                          ISO 14001
 EMS- General Guidelines on          EMS- Specification with
  Principles, Systems and          Guidance for Use requires a
   Supporting Techniques          substantial commitment of time
                                          and resources
                                 Department of Pharmaceutics   9/2/2012   41
ISO 14004                        ISO 14010
EMS - General Guidelines          EA- General Principles of
on Systems, Principles and         Environmental Auditing
  Supporting Techniques
                                        ISO 14012
        ISO 14011               EA- Qualification Criteria for
      EA- Auditing of             Environmental Auditors
Environmental Management
         Systems
                                       ISO 14014
                                     Initial Reviews
      ISO 14013
                                       ISO 14015
    Management of
  Environmental Audit        Environmental Site Assessments
       Programs
                                         ISO 14021
       ISO 14020
                                    EL- Self Declaration-
 EL- Basic Principles of
                                Environmental Claims- Terms
 Environmental Labeling
                                       and Definitions
                             Department of Pharmaceutics   9/2/2012   42
ISO 14022 EL- Symbols                     ISO 14024
        ISO 14023                 EL- Practitioner Programs-
EL- Testing and Verification      Guiding principles, practices
      Methodologies               and certification procedures
                                   of multiple criteria (type1)
        ISO 14031
                                         ISO 14040
Environmental Performance
                                  LCA- General Principles and
        Evaluation
                                          Practices
         ISO 14041
                                            ISO 14042
      LCA- Goal and
                                     LCA- Impact Assessment
    Definition/Scope and
                                            ISO 14043
   Inventory Assessment
                                       LCA- Improvement
        ISO 14060                          Assessment
 Guide for the Inclusion of                 ISO 14050
 Environmental Aspects in
                                        Terms and Definitions
   Product Standards
                               Department of Pharmaceutics   9/2/2012   43
Guides To Pharmaceutical Manufacturing
Facilities & Productivity


  Quality
  Facilities and Equipment
  Materials
  Production
  Packaging/Labeling
  Laboratory Controls




                         Department of Pharmaceutics   9/2/2012   44
Need of guidelines in pharmaceuticals
facilities & productivity
  Detailed guidelines of a system so that the
   findings reflect the state of control in that
   system for every product (profile) class
  If one of the six systems is out of control, the
   firm is considered out of control
  A system is considered out of control based on
   GMP deficiencies which suggest lack of
   assurance of quality


                         Department of Pharmaceutics   9/2/2012   45
Quality System

           Quality must be built into the
           process


                         Quality is not tested into the product
      Quality
      System              Assurance of Quality comes from
                              - Design of robust process based on
                        thorough knowledge of that process and the
                                   sources of variability


Effective Quality System in place

                               Department of Pharmaceutics   9/2/2012   46
Role of Management in QS
 Management is responsible for:


 Organizational structure
 All Processes
 All Procedures
 Facilities & Resources


 In short, everything to insure product quality, customer
  satisfaction and continuous improvement




                               Department of Pharmaceutics   9/2/2012   47
Quality System Responsibilities

 Assures overall compliance          6) Reprocess/ Rework
     with cGMPs                       7) Validation/ Revalidation
    Review and approval duties       8) Rejects
     for:
                                      9) Stability Failures/ Out of
1)   Product Quality Reviews (at         trend data
     least annually)
                                      10) Quarantine products
2)   Complaint reviews
                                      11) Documented GMP & Job
3)   Discrepancy/ failure                Related Training
     investigations
4)   Change Control
5)   CAPA (Corrective And
     Preventive Action)

                                   Department of Pharmaceutics   9/2/2012   48
Laboratory Control System (I)
Adequately staffed laboratories (supervisory
and bench personnel)

                                     Written specifications for raw
                                     materials, intermediates, APIs, label
 Laboratory Control                  s & packaging
 System:                           Written procedures for sampling,
                                   testing, approval or rejection of
 Adequate lab facilities           materials and for the recording and
 under the Quality Unit            storage of data
 which is independent
 from Production
                                 Method validation/ revalidation



      Validation and Security for computerized handling of test results
      and related data; system for assuring integrity of all lab data
                                     Department of Pharmaceutics   9/2/2012   49
Laboratory Control System (II)
Reference Standards (primary; secondary)


                                Laboratory controls followed and
                                documented

 Laboratory Control
 System                           Calibration: written
                                  procedures, schedule, documentation


                                 Equipment Qualification



  Written procedure (SOP) covering out of specification “oos” results

                                     Department of Pharmaceutics   9/2/2012   50
Laboratory Control System (III)

                  Investigation of “oos” results conducted in a timely
                  manner as per SOP and documented (complete
                  records maintained).



Laboratory                 Conclusions from “oos” investigations
Control                    documented and corrective actions/ need
System                     for addition investigation identified and
                           implemented.


                       “oos” review included in Product
                       Quality Reviews

                    Description of samples
                 Identification of method used
      Raw data for sample/ standard preparation, reagents
                                Department of Pharmaceutics   9/2/2012   51
Laboratory Control System (IV)
   Complete record of all data from testing
         Record of all calculations

                               Statement of the test results; how
                               compare with established acceptance
                               criteria

Laboratory Control
System
                                 Signature of the person who performed
                                 each test; dates tests performed




 Date/ signature of second qualified person who reviewed original test
 records for accuracy, completeness and compliance with established
 standards
                                    Department of Pharmaceutics   9/2/2012   52
Training
                   (documente
                      d; job-
                     related)


Implementation
and
documentation            Production
of in-process            System (I)
controls, tests,
and
examinations


                    Contemporaneous, accura
                      te and complete batch
                    production documentation

                                Department of Pharmaceutics   9/2/2012   53
Production system (II)

        Adequate written procedures & practice
              for charge-in of materials


       Identification of equipment with contents,
            stage of manufacturing, status


              Equipment cleaning records


         Established time limits for completion of
                 production steps/ stages

        Deviations investigated and documented
          contemporaneously with investigation
                            Department of Pharmaceutics   9/2/2012   54
Production system (III)


    Process validation based on knowledge of process
        (scientific basis for identifying critical steps/
         critical process parameters/control points)




        Justification and consistency of in-process
       specifications and final product specifications



        Data/ information documented and available
    to Quality Unit for review (trending, investigations etc.)


                               Department of Pharmaceutics   9/2/2012   55
Facilities & Equipment System
Location, design, construction appropriate to facilitate
cleaning, maintenance, operations

                                    Layout and air handling designed and
                                       constructed to prevent cross-
                                               contamination

 Facilities &
 Equipment                           Flow of materials & personnel designed
 System                                to prevent mix-ups or contamination




        Defined areas or other control systems to prevent mix-ups or
                        contamination includes as:
                                       Department of Pharmaceutics   9/2/2012   56
Facilities & Equipment System
  Incoming materials
    (id, quarantine)                   Sampling area (prevent
                                          contamination)


                                     Quarantine (intermediates, APIs)


Facilities &
                                                  Released materials
Equipment
System
                                                  Rejection


                                 b) EQUIPMENTS

     Appropriate design, size, location, non-reactive product
                        contact surfaces
                                  Department of Pharmaceutics   9/2/2012   57
Facilities & Equipment System
    Identification clearly
           marked                              Calibration

                                        Preventive Maintenance schedule
                                                 and procedures

  Facilities &                           Cleaning procedures and validation
  Equipment
  System: b)                                 Records of
                                     use, cleaning, maintenance
  EQUIPMENTS
                                    Closed or contained equipment.             -
                                          Inspection prior to use

Separate facilities or containment where needed (penicillin's, highly
potent compounds etc.)
                                      Department of Pharmaceutics   9/2/2012       58
Utilities
    Qualified and appropriately monitored;
        drawings should be available


                                 Designed and constructed to prevent
                                 contamination or cross-contamination



    Utilities                           Recirculated air to production
                                              (same concern)


                             Permanently installed pipe work should be
                                    appropriately identified


Drains of adequate size with air break

                                  Department of Pharmaceutics   9/2/2012   59
Water
       Process water at minimum meeting WHO
             guidelines for potable water


                                          Justify quality of water used to
                                          achieve stated API quality and
                                             establish specifications


       Water
                                  Water treatment facilities validation




 API to be used for incorporation into sterile dosage form – water used in
later stages should be monitored and controlled for total microbial counts,
                 objectionable organisms and endotoxins
                                     Department of Pharmaceutics   9/2/2012   60
Materials System
      Written procedures for receipt, identification,
   quarantine, storage, handling, sampling, testing and
            approval or rejection of materials


                         System to evaluate suppliers (critical materials)
                            Purchased against agreed specification


     Materials
                                          Change control process for
     System                                  changing suppliers

                               Upon receipt check for correct labeling,
                                                seals
                               Before co-mingling bulk material, id/test

Assurances obtained from non-dedicated
tankers
                                    Department of Pharmaceutics   9/2/2012   61
Materials System
  Identification on large storage containers and
 associated manifolds, filling and discharge lines



                      Code given to received batches; status identity



 Materials
                                At minimum, a specific identity test
 System                         on incoming batches.

                           Supplier evaluation should include three
                             fully tested batches; one fully tested
                                           batch/year

   Written sampling plan with justification
Prevent contamination of sampled containers
                                Department of Pharmaceutics   9/2/2012   62
Materials System
  Stored in manner to prevent degradation,
 contamination, no adverse effect on quality



                          Drums, bags, boxes off the floor


Materials
System                                       First in, first out


                           Rejected materials identified and
                         controlled under a quarantine system


Established re-test/ re-evaluation periods
                             Department of Pharmaceutics   9/2/2012   63
Packaging & Labeling System

    Written procedures for receipt, identification,
quarantine, sampling, examination and/or testing P&L


        P&L should conform to specifications

       Records maintained for each shipment
       (showing receipt, examination & result)

   Containers protective, clean, not alter product
   quality; if re-used, cleaned & labeling defaced

        Access to label storage area limited

       Written procedures for reconciliation;
            - investigation if discrepancy
                         Department of Pharmaceutics   9/2/2012   64
Packaging & Labeling System

 All excess labels with batch #, destroyed


         Obsolete labels destroyed

Printing devices controlled to insure accuracy
         of label (against batch record)

   Print labels checked against master
  and a copy placed into the batch record

Documented procedures to assure correct
    packaging materials/ labels used

  Operations designed to prevent mix-ups

                     Department of Pharmaceutics   9/2/2012   65
Packaging & Labeling System

   Labels: API name, batch #, storage conditions

Shipped API: Name/ address manufacturer; special
      transport conditions; expiry/ retest date

     Documented clearance before operations

     Packaged/ labeled intermediates or APIs
   examined as part of packaging (documented)

    Seal employed to assure package integrity




                         Department of Pharmaceutics   9/2/2012   66
Benefits
 Certification demonstrates the recognition of quality
  throughout organization

 Decrease in wasted time, materials, and efforts.

 Inculcating values of excellence and best practices.

 Establish leadership role within organization.

 Increased recognition by international partners

 Ability to maintain standards of quality and
  excellence.

                                Department of Pharmaceutics   9/2/2012   67
References

     Lachman L. Lieberman A. Kanig JL. The
      Theory Of Industrial Pharmacy, 2nd edi,
       Varghese Publication House; Bombay-14
     Gilbert s. Banker, Christoher T. Rhodes,
       Modern Pharmaceutics, 3rd edi, New York.
     Sharma PP. How To Practice GMPs, 2nd edi,
       Vandana Publication; Agra.
     www.google.com
     www.wikipedia.com
     www.kwaliteg.co.za.iso:9000.com
     www.fda.com

                             Department of Pharmaceutics   9/2/2012   68
Department of Pharmaceutics   9/2/2012   69

More Related Content

What's hot

PHARMACEUTICAL VALIDATION
 PHARMACEUTICAL  VALIDATION PHARMACEUTICAL  VALIDATION
PHARMACEUTICAL VALIDATION
SACHIN C P
 
Validation master plan
Validation master planValidation master plan
Validation master plan
Dr. Amsavel A
 
Ich guideline for stability testing
Ich guideline for stability testingIch guideline for stability testing
Ich guideline for stability testing
Shubham Gore
 
Quality assurance and regulatory compliance for pharmaceutical product
Quality assurance and regulatory compliance for pharmaceutical productQuality assurance and regulatory compliance for pharmaceutical product
Quality assurance and regulatory compliance for pharmaceutical product
Prof. Dr. Basavaraj Nanjwade
 
Quality control measures in pharmaceutical industry
Quality control measures in pharmaceutical industryQuality control measures in pharmaceutical industry
Quality control measures in pharmaceutical industry
ChemOnTheGo
 
Out of specification shravan
Out of specification shravanOut of specification shravan
Out of specification shravan
shravan dubey
 
batch formula record and master formula record
batch formula record and master formula recordbatch formula record and master formula record
batch formula record and master formula record
RashmitaPoojary1
 
BMR (Batch Manufacturing Record)
BMR (Batch Manufacturing Record)BMR (Batch Manufacturing Record)
BMR (Batch Manufacturing Record)Ram Mohan S R
 
cGMP.
cGMP.cGMP.
Quality assurance audits in pharma industries
Quality assurance audits in pharma industries Quality assurance audits in pharma industries
Quality assurance audits in pharma industries
rasika walunj
 
Qualification & Validation
Qualification & ValidationQualification & Validation
Qualification & Validation
ICHAPPS
 
Master formula record
Master formula recordMaster formula record
Master formula record
Doninder Hooda
 
Quality Control tests for pharmaceutical containers, closures and secondary p...
Quality Control tests for pharmaceutical containers, closures and secondary p...Quality Control tests for pharmaceutical containers, closures and secondary p...
Quality Control tests for pharmaceutical containers, closures and secondary p...
Sanathoiba Singha
 
Quality audit
Quality auditQuality audit
Quality audit
Doninder Hooda
 
Document Maintenance in Pharmaceutical Industry
Document Maintenance in Pharmaceutical IndustryDocument Maintenance in Pharmaceutical Industry
Document Maintenance in Pharmaceutical Industry
NAKUL DHORE
 
Out of specification (oos)1
Out of specification (oos)1Out of specification (oos)1
Out of specification (oos)1
Dr. Ravi Kinhikar
 
ICH GUIDELINE SPECIFIC WITH Q SERIES
ICH GUIDELINE SPECIFIC WITH Q SERIESICH GUIDELINE SPECIFIC WITH Q SERIES
ICH GUIDELINE SPECIFIC WITH Q SERIES
HEALY LAD
 
Pharmaceutical validation ppt Rahul Dalvi
Pharmaceutical validation ppt Rahul DalviPharmaceutical validation ppt Rahul Dalvi
Pharmaceutical validation ppt Rahul Dalvi
Rahul Dalvi
 

What's hot (20)

PHARMACEUTICAL VALIDATION
 PHARMACEUTICAL  VALIDATION PHARMACEUTICAL  VALIDATION
PHARMACEUTICAL VALIDATION
 
Process validation
Process validationProcess validation
Process validation
 
Validation master plan
Validation master planValidation master plan
Validation master plan
 
Ich guideline for stability testing
Ich guideline for stability testingIch guideline for stability testing
Ich guideline for stability testing
 
Quality assurance and regulatory compliance for pharmaceutical product
Quality assurance and regulatory compliance for pharmaceutical productQuality assurance and regulatory compliance for pharmaceutical product
Quality assurance and regulatory compliance for pharmaceutical product
 
Quality control measures in pharmaceutical industry
Quality control measures in pharmaceutical industryQuality control measures in pharmaceutical industry
Quality control measures in pharmaceutical industry
 
Out of specification shravan
Out of specification shravanOut of specification shravan
Out of specification shravan
 
batch formula record and master formula record
batch formula record and master formula recordbatch formula record and master formula record
batch formula record and master formula record
 
BMR (Batch Manufacturing Record)
BMR (Batch Manufacturing Record)BMR (Batch Manufacturing Record)
BMR (Batch Manufacturing Record)
 
cGMP.
cGMP.cGMP.
cGMP.
 
Quality assurance audits in pharma industries
Quality assurance audits in pharma industries Quality assurance audits in pharma industries
Quality assurance audits in pharma industries
 
Qualification & Validation
Qualification & ValidationQualification & Validation
Qualification & Validation
 
Master formula record
Master formula recordMaster formula record
Master formula record
 
Quality Control tests for pharmaceutical containers, closures and secondary p...
Quality Control tests for pharmaceutical containers, closures and secondary p...Quality Control tests for pharmaceutical containers, closures and secondary p...
Quality Control tests for pharmaceutical containers, closures and secondary p...
 
Quality audit
Quality auditQuality audit
Quality audit
 
Document Maintenance in Pharmaceutical Industry
Document Maintenance in Pharmaceutical IndustryDocument Maintenance in Pharmaceutical Industry
Document Maintenance in Pharmaceutical Industry
 
BMR & MFR
BMR & MFRBMR & MFR
BMR & MFR
 
Out of specification (oos)1
Out of specification (oos)1Out of specification (oos)1
Out of specification (oos)1
 
ICH GUIDELINE SPECIFIC WITH Q SERIES
ICH GUIDELINE SPECIFIC WITH Q SERIESICH GUIDELINE SPECIFIC WITH Q SERIES
ICH GUIDELINE SPECIFIC WITH Q SERIES
 
Pharmaceutical validation ppt Rahul Dalvi
Pharmaceutical validation ppt Rahul DalviPharmaceutical validation ppt Rahul Dalvi
Pharmaceutical validation ppt Rahul Dalvi
 

Similar to ISO series, guide of pharmaceutical manufacturing facilities, productivity by kailash vilegave

PECB Webinar: ISO 9001:2015 Transition – Understanding the changes
PECB Webinar: ISO 9001:2015 Transition – Understanding the changes PECB Webinar: ISO 9001:2015 Transition – Understanding the changes
PECB Webinar: ISO 9001:2015 Transition – Understanding the changes
PECB
 
Qms iso 9000 (ISO 9000 series of quality systems standards)
Qms  iso 9000 (ISO 9000 series of quality systems standards)Qms  iso 9000 (ISO 9000 series of quality systems standards)
Qms iso 9000 (ISO 9000 series of quality systems standards)
Dr Ajay Kumar Tiwari
 
Iso 9000 2000 Prs
Iso 9000 2000 PrsIso 9000 2000 Prs
Iso 9000 2000 Prsshajukhan21
 
INTERNATIONAL ORGANIZATION FOR STANDARDIZATION(ISO)
INTERNATIONAL ORGANIZATION FOR STANDARDIZATION(ISO)INTERNATIONAL ORGANIZATION FOR STANDARDIZATION(ISO)
INTERNATIONAL ORGANIZATION FOR STANDARDIZATION(ISO)
waseemakhtar120
 
RME-085 TQM (unit-5 part 1)
RME-085 TQM (unit-5  part 1)RME-085 TQM (unit-5  part 1)
RME-085 TQM (unit-5 part 1)
ssuserf6c4bd
 
Quality managment impacts in construction
Quality managment impacts in constructionQuality managment impacts in construction
Quality managment impacts in constructionKhaled Eid
 
ISO 9000
ISO 9000ISO 9000
ISO 9000
Snehal Nemane
 
Ch13 Iso 9000
Ch13 Iso 9000Ch13 Iso 9000
Ch13 Iso 9000ajithsrc
 
ISO 9001 implementation in IT Companies
ISO 9001 implementation in IT CompaniesISO 9001 implementation in IT Companies
ISO 9001 implementation in IT Companiesannoyket
 
QMS.pdf
QMS.pdfQMS.pdf
QMS.pdf
Khariharan13
 
tuvsud-ISO-9001-2015-guidance.pdf
tuvsud-ISO-9001-2015-guidance.pdftuvsud-ISO-9001-2015-guidance.pdf
tuvsud-ISO-9001-2015-guidance.pdf
HalaGhaziAyoub
 
ISO 9000 certification(Quality Management System)
ISO 9000 certification(Quality Management System)ISO 9000 certification(Quality Management System)
ISO 9000 certification(Quality Management System)
Varshid Patel
 
Inspection and quality control
Inspection and quality controlInspection and quality control
Inspection and quality control
Afrozamjad
 
JAY ISO 9000
JAY ISO 9000JAY ISO 9000
JAY ISO 9000jay shah
 
ISO 9000
ISO 9000ISO 9000
ISO 9000
Haroon Abbu
 
ISO 9000:2000
ISO 9000:2000ISO 9000:2000
ISO 9000:2000
WBUAFS
 

Similar to ISO series, guide of pharmaceutical manufacturing facilities, productivity by kailash vilegave (20)

ISO 9001:2008 in school
ISO 9001:2008 in schoolISO 9001:2008 in school
ISO 9001:2008 in school
 
TQM Unit 7, VTU Syallabus
TQM Unit 7, VTU SyallabusTQM Unit 7, VTU Syallabus
TQM Unit 7, VTU Syallabus
 
PECB Webinar: ISO 9001:2015 Transition – Understanding the changes
PECB Webinar: ISO 9001:2015 Transition – Understanding the changes PECB Webinar: ISO 9001:2015 Transition – Understanding the changes
PECB Webinar: ISO 9001:2015 Transition – Understanding the changes
 
Qms iso 9000 (ISO 9000 series of quality systems standards)
Qms  iso 9000 (ISO 9000 series of quality systems standards)Qms  iso 9000 (ISO 9000 series of quality systems standards)
Qms iso 9000 (ISO 9000 series of quality systems standards)
 
Iso 9000 2000 Prs
Iso 9000 2000 PrsIso 9000 2000 Prs
Iso 9000 2000 Prs
 
INTERNATIONAL ORGANIZATION FOR STANDARDIZATION(ISO)
INTERNATIONAL ORGANIZATION FOR STANDARDIZATION(ISO)INTERNATIONAL ORGANIZATION FOR STANDARDIZATION(ISO)
INTERNATIONAL ORGANIZATION FOR STANDARDIZATION(ISO)
 
RME-085 TQM (unit-5 part 1)
RME-085 TQM (unit-5  part 1)RME-085 TQM (unit-5  part 1)
RME-085 TQM (unit-5 part 1)
 
Quality managment impacts in construction
Quality managment impacts in constructionQuality managment impacts in construction
Quality managment impacts in construction
 
ISO 9000
ISO 9000ISO 9000
ISO 9000
 
Ch13 Iso 9000
Ch13 Iso 9000Ch13 Iso 9000
Ch13 Iso 9000
 
ISO 9001 implementation in IT Companies
ISO 9001 implementation in IT CompaniesISO 9001 implementation in IT Companies
ISO 9001 implementation in IT Companies
 
QMS.pdf
QMS.pdfQMS.pdf
QMS.pdf
 
Iso
IsoIso
Iso
 
Iso shz
Iso shzIso shz
Iso shz
 
tuvsud-ISO-9001-2015-guidance.pdf
tuvsud-ISO-9001-2015-guidance.pdftuvsud-ISO-9001-2015-guidance.pdf
tuvsud-ISO-9001-2015-guidance.pdf
 
ISO 9000 certification(Quality Management System)
ISO 9000 certification(Quality Management System)ISO 9000 certification(Quality Management System)
ISO 9000 certification(Quality Management System)
 
Inspection and quality control
Inspection and quality controlInspection and quality control
Inspection and quality control
 
JAY ISO 9000
JAY ISO 9000JAY ISO 9000
JAY ISO 9000
 
ISO 9000
ISO 9000ISO 9000
ISO 9000
 
ISO 9000:2000
ISO 9000:2000ISO 9000:2000
ISO 9000:2000
 

More from Kailash Vilegave

Amino acid
Amino acidAmino acid
Amino acid
Kailash Vilegave
 
Amino acid
Amino acid Amino acid
Amino acid
Kailash Vilegave
 
Advances in Transdermal drug delivery system by Kailash vilegave
Advances in Transdermal drug delivery system by Kailash vilegave Advances in Transdermal drug delivery system by Kailash vilegave
Advances in Transdermal drug delivery system by Kailash vilegave
Kailash Vilegave
 
Transdermal drug delivery system by Kailash Vilegave
Transdermal drug delivery system by Kailash VilegaveTransdermal drug delivery system by Kailash Vilegave
Transdermal drug delivery system by Kailash Vilegave
Kailash Vilegave
 
Transmucosal drug delivery by Kailash Vilegave
Transmucosal drug delivery by Kailash VilegaveTransmucosal drug delivery by Kailash Vilegave
Transmucosal drug delivery by Kailash Vilegave
Kailash Vilegave
 
Chapter 20 locomotion and movement
Chapter 20 locomotion and movementChapter 20 locomotion and movement
Chapter 20 locomotion and movement
Kailash Vilegave
 
Chapter 17 breathing & exchange of gases part 1
Chapter 17 breathing & exchange of gases part 1Chapter 17 breathing & exchange of gases part 1
Chapter 17 breathing & exchange of gases part 1
Kailash Vilegave
 
Chapter 17 breathing & exchange of gases (repaired) (2)
Chapter 17 breathing & exchange of gases (repaired) (2)Chapter 17 breathing & exchange of gases (repaired) (2)
Chapter 17 breathing & exchange of gases (repaired) (2)
Kailash Vilegave
 
Chapter 14 respiration in plants chapter.
Chapter 14 respiration in plants chapter.Chapter 14 respiration in plants chapter.
Chapter 14 respiration in plants chapter.
Kailash Vilegave
 
Parenterals products by Kailash vilegave
Parenterals products by Kailash vilegave Parenterals products by Kailash vilegave
Parenterals products by Kailash vilegave
Kailash Vilegave
 
Preformulation stability studies, physicochemical parameters affecting prefor...
Preformulation stability studies, physicochemical parameters affecting prefor...Preformulation stability studies, physicochemical parameters affecting prefor...
Preformulation stability studies, physicochemical parameters affecting prefor...
Kailash Vilegave
 
Kingdom Plantae presented by Vrushali Gharat to Mr. Kailash vilegave
Kingdom Plantae presented by Vrushali Gharat to Mr. Kailash vilegaveKingdom Plantae presented by Vrushali Gharat to Mr. Kailash vilegave
Kingdom Plantae presented by Vrushali Gharat to Mr. Kailash vilegave
Kailash Vilegave
 
Kingdom plantae by Sayali Diwan presented to Mr. Kailash Vilegave ( Navdhare ...
Kingdom plantae by Sayali Diwan presented to Mr. Kailash Vilegave ( Navdhare ...Kingdom plantae by Sayali Diwan presented to Mr. Kailash Vilegave ( Navdhare ...
Kingdom plantae by Sayali Diwan presented to Mr. Kailash Vilegave ( Navdhare ...
Kailash Vilegave
 
Unit 3 by kailash sir cell structure & function kp
Unit 3 by kailash sir    cell structure & function kpUnit 3 by kailash sir    cell structure & function kp
Unit 3 by kailash sir cell structure & function kp
Kailash Vilegave
 
Osmotic drug delivery system by Mr. kailash vilegave
Osmotic drug delivery system by Mr. kailash vilegaveOsmotic drug delivery system by Mr. kailash vilegave
Osmotic drug delivery system by Mr. kailash vilegave
Kailash Vilegave
 
Osmotic drug delivery system by Mr. kailash vilegave
Osmotic drug delivery system by Mr. kailash vilegaveOsmotic drug delivery system by Mr. kailash vilegave
Osmotic drug delivery system by Mr. kailash vilegave
Kailash Vilegave
 
Pilotplantscale uptechniques by kailash vilegave
Pilotplantscale uptechniques by kailash vilegavePilotplantscale uptechniques by kailash vilegave
Pilotplantscale uptechniques by kailash vilegave
Kailash Vilegave
 
Gmp cgmp qa considerations- by Mr. Kailash Vilegave
Gmp cgmp  qa considerations- by Mr. Kailash VilegaveGmp cgmp  qa considerations- by Mr. Kailash Vilegave
Gmp cgmp qa considerations- by Mr. Kailash VilegaveKailash Vilegave
 
Seminar on inventory management by kailash vilegave
Seminar on inventory management by kailash vilegaveSeminar on inventory management by kailash vilegave
Seminar on inventory management by kailash vilegave
Kailash Vilegave
 
Capsule 1 manufacturing and qc test by Kailash Vilegave
Capsule 1 manufacturing and qc test by Kailash VilegaveCapsule 1 manufacturing and qc test by Kailash Vilegave
Capsule 1 manufacturing and qc test by Kailash Vilegave
Kailash Vilegave
 

More from Kailash Vilegave (20)

Amino acid
Amino acidAmino acid
Amino acid
 
Amino acid
Amino acid Amino acid
Amino acid
 
Advances in Transdermal drug delivery system by Kailash vilegave
Advances in Transdermal drug delivery system by Kailash vilegave Advances in Transdermal drug delivery system by Kailash vilegave
Advances in Transdermal drug delivery system by Kailash vilegave
 
Transdermal drug delivery system by Kailash Vilegave
Transdermal drug delivery system by Kailash VilegaveTransdermal drug delivery system by Kailash Vilegave
Transdermal drug delivery system by Kailash Vilegave
 
Transmucosal drug delivery by Kailash Vilegave
Transmucosal drug delivery by Kailash VilegaveTransmucosal drug delivery by Kailash Vilegave
Transmucosal drug delivery by Kailash Vilegave
 
Chapter 20 locomotion and movement
Chapter 20 locomotion and movementChapter 20 locomotion and movement
Chapter 20 locomotion and movement
 
Chapter 17 breathing & exchange of gases part 1
Chapter 17 breathing & exchange of gases part 1Chapter 17 breathing & exchange of gases part 1
Chapter 17 breathing & exchange of gases part 1
 
Chapter 17 breathing & exchange of gases (repaired) (2)
Chapter 17 breathing & exchange of gases (repaired) (2)Chapter 17 breathing & exchange of gases (repaired) (2)
Chapter 17 breathing & exchange of gases (repaired) (2)
 
Chapter 14 respiration in plants chapter.
Chapter 14 respiration in plants chapter.Chapter 14 respiration in plants chapter.
Chapter 14 respiration in plants chapter.
 
Parenterals products by Kailash vilegave
Parenterals products by Kailash vilegave Parenterals products by Kailash vilegave
Parenterals products by Kailash vilegave
 
Preformulation stability studies, physicochemical parameters affecting prefor...
Preformulation stability studies, physicochemical parameters affecting prefor...Preformulation stability studies, physicochemical parameters affecting prefor...
Preformulation stability studies, physicochemical parameters affecting prefor...
 
Kingdom Plantae presented by Vrushali Gharat to Mr. Kailash vilegave
Kingdom Plantae presented by Vrushali Gharat to Mr. Kailash vilegaveKingdom Plantae presented by Vrushali Gharat to Mr. Kailash vilegave
Kingdom Plantae presented by Vrushali Gharat to Mr. Kailash vilegave
 
Kingdom plantae by Sayali Diwan presented to Mr. Kailash Vilegave ( Navdhare ...
Kingdom plantae by Sayali Diwan presented to Mr. Kailash Vilegave ( Navdhare ...Kingdom plantae by Sayali Diwan presented to Mr. Kailash Vilegave ( Navdhare ...
Kingdom plantae by Sayali Diwan presented to Mr. Kailash Vilegave ( Navdhare ...
 
Unit 3 by kailash sir cell structure & function kp
Unit 3 by kailash sir    cell structure & function kpUnit 3 by kailash sir    cell structure & function kp
Unit 3 by kailash sir cell structure & function kp
 
Osmotic drug delivery system by Mr. kailash vilegave
Osmotic drug delivery system by Mr. kailash vilegaveOsmotic drug delivery system by Mr. kailash vilegave
Osmotic drug delivery system by Mr. kailash vilegave
 
Osmotic drug delivery system by Mr. kailash vilegave
Osmotic drug delivery system by Mr. kailash vilegaveOsmotic drug delivery system by Mr. kailash vilegave
Osmotic drug delivery system by Mr. kailash vilegave
 
Pilotplantscale uptechniques by kailash vilegave
Pilotplantscale uptechniques by kailash vilegavePilotplantscale uptechniques by kailash vilegave
Pilotplantscale uptechniques by kailash vilegave
 
Gmp cgmp qa considerations- by Mr. Kailash Vilegave
Gmp cgmp  qa considerations- by Mr. Kailash VilegaveGmp cgmp  qa considerations- by Mr. Kailash Vilegave
Gmp cgmp qa considerations- by Mr. Kailash Vilegave
 
Seminar on inventory management by kailash vilegave
Seminar on inventory management by kailash vilegaveSeminar on inventory management by kailash vilegave
Seminar on inventory management by kailash vilegave
 
Capsule 1 manufacturing and qc test by Kailash Vilegave
Capsule 1 manufacturing and qc test by Kailash VilegaveCapsule 1 manufacturing and qc test by Kailash Vilegave
Capsule 1 manufacturing and qc test by Kailash Vilegave
 

Recently uploaded

Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
Steve Thomason
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
PedroFerreira53928
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxStudents, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
EduSkills OECD
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
Excellence Foundation for South Sudan
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
rosedainty
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
Vivekanand Anglo Vedic Academy
 

Recently uploaded (20)

Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxStudents, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
 

ISO series, guide of pharmaceutical manufacturing facilities, productivity by kailash vilegave

  • 1. Seminar on …… ISO series, guide of pharmaceutical manufacturing facilities, productivity By : Mr. Kailash Vilegave. Assit prof. Shivajirao S Jondhle college of pharmacy Asangaon 421601 Department of Pharmaceutics 9/2/2012 1
  • 2. Contents  Introduction.  History.  ISO: 9000 series.  ISO:14000 series.  Guide to Pharmaceutical Manufacturing Facilities, Productivity.  References. Department of Pharmaceutics 9/2/2012 2
  • 3. Introduction What are ISO 9000 Standards?  ISO 9000 Standards  Define the required elements of an effective quality management system  Can be applied to any company  Adopted by the United States as the ANSI/ASQC Q90 series. STANDARD BODIES 154 COUNTRIES Bureau of Standards Jamaica Department of Pharmaceutics 9/2/2012 3
  • 4. Background Who Created Standards • ISO WAS FORMED FEBRUARY 23, 1947 IN GENEVA • FIRST FAMILY OF QUALITY STANDARD RELEASED 1987 – To eliminate country to country differences – To eliminate terminology confusion – To increase quality awareness • FIRST ENVIRONMENTAL STANDARD RELEASED IN 1996 Department of Pharmaceutics 9/2/2012 4
  • 5. How did ISO get started? 1906 - International Electro-technical Commission 1926 - International Federation of the National Standardizing Associations (ISA) 1946 London - delegates from 25 countries decided to create a new international organization "the object of which would be to facilitate the international coordination and unification of industrial standards 1947 - ISO began to officially function 1951 - The first ISO standard was published "Standard reference temperature for industrial length measurement". Department of Pharmaceutics 9/2/2012 5
  • 6. ISO 9000 Consists of 5 Documents ISO 9000 Quality Management and Quality Assurance Standards ISO 9001 Quality Systems - QA Model for Design/Development, Production, Installation, and Service ISO 9002 Quality Systems - QA Model for Production and Installation (no design) ISO 9003 Quality Systems - QA Model for Final Inspection and Test ISO 9004 Quality Management and Quality System Elements - Guidelines Department of Pharmaceutics 9/2/2012 6
  • 7. ISO 9000 Family of Standards •ISO 9000-2 - Generic guidelines for applying ISO 9001, ISO 9002, and •ISO 9003 ISO 9000-3 - Guidelines for applying ISO 9001 to the development, supply, and maintenance of software ISO 9000-4 Application for dependability management ISO 9004-2 Guidelines for services ISO 9004-3 Guidelines for processed material ISO 9004-4 Guidelines for quality improvement ISO 9004-5 Guidelines for quality plans •ISO 9004-6,7- Guidelines for project & configuration management Department of Pharmaceutics 9/2/2012 7
  • 8. What has ISO Accomplished? • ISO film speed code • TL9000 Standard format for telephone and banking cards • ISO 9000 which provides a framework for quality management and quality assurance • ISO 14000 series provides a similar framework for environmental management • Internationally standardized freight containers • Standardized paper sizes. • Automobile control symbols • ISO international codes for country names, currencies and languages • AS 9100 the Aerospace Basic Quality System Standard Department of Pharmaceutics 9/2/2012 8
  • 9. ISO 9000:1987 series ISO 9000:1994 series International Organisation ISO 9000 was revised in for Standards (ISO) adopted 1994 a series of quality standards, ISO 9000:1987 greater emphasis on quality assurance via preventive based on BS5750 actions. strongly influenced by the required evidence of US Department of Defence compliance with Military Standards documented procedures (MILspecs). tended to create a initial version was focused significant volume of on quality control using associated procedure retroactive checking ("do it as you document it") and corrective actions. manuals and bureaucracy. Department of Pharmaceutics 9/2/2012 9
  • 10. QS-9000 ISO9000:2000 series Ford, Chrysler, General 2nd revision of Quality Motors and other Management System automotive/truck Requirement Standard from manufacturers identified International Organization for deficiencies in Standards ISO9000:1994 moved towards undertook a re- process performance metrics interpretation and reduced the need for extension to develop QS- documented procedures 9000 where clear evidence exists that the process is working additionally addressed well. continuous improvement, manufacturin Replacement for previous ISO g capability and production 9001 / 9002 and 9003 part approval processes. standards of 1994 Department of Pharmaceutics 9/2/2012 10
  • 11. ISO9000:2000 Future series Version : 2008  standards provide criteria for companies to TC 176, the ISO 9001  "certify" their quality technical committee management , has started its review on the next version of ISO  recertification is required 9001, which will in all every three years likelihood be termed the  achieve "registration" by third- ISO 9001:2008 party auditor. standard, assuming its planned release date of  the system 2008 is met. Early reports  verifies practice and are that the standard will processes not be substantially  provides objective 3rd changed from its 2000 version. party validation  enables benchmarking. Department of Pharmaceutics 9/2/2012 11
  • 12. New ISO 9001 Management Responsibility Measurement, General Resource analysis & General requirements management QMS improvements requirements Product Realization Continual Improvement cycle Department of Pharmaceutics 9/2/2012 12
  • 13. ISO 9001: Model Continual Improvement of the Quality Management System 5.Management Responsibility CUSTOMERS CUSTOMERS Quality Management Satisfaction 6. Resource 8. Measurement Analysis and Management Improvement System 7. Product Requirements Product Consumption Realization Department of Pharmaceutics 9/2/2012 13
  • 14. Principle Of New Standards Customer focus Mutual beneficial supplier relationshi Based on eight p quality management Factual principles approach to decision making System Continual approach improveme to nt Manageme nt Department of Pharmaceutics 9/2/2012 14
  • 15. Principles of new standard Customer focus •Organization depends customers •Understand current & future customer needs. •Meet / exceed customer expectations Leadership •Leaders establish purpose & direction of the organization •Should create & maintain environment to achieve organization’s objectives Involvement of People •People of all levels are essence of an organization •Their full involvement for organization’s benefit Process approach Desired results are achieved more efficiently when activities and resources are managed as process Department of Pharmaceutics 9/2/2012 15
  • 16. Principles of new standard System approach to Management Identifying, understanding and managing interrelated process as a system contributes to the organization’s effectiveness & efficiency Continual improvements Continual improvement of the organization’s overall performance should be a permanent objective of the organization Factual approach to decision making Effective decisions are based on the analysis of data and information Mutually beneficial supplier relationships •An organization & its suppliers are interdependent •Mutually beneficial relationship enhances the ability of both to create value Department of Pharmaceutics 9/2/2012 16
  • 17. Expectations of the new Standard Avoid the application of systems that are separate from the organization’s business process Enable the development of a Quality system that is fully integrated into the normal operations of organization’s business Enable Continual improvements of the system for enhanced customer satisfaction Enable compliance to statutory & regulatory requirements Department of Pharmaceutics 9/2/2012 17
  • 18. Important changes Criteria Previous version New Version Main focus Products Customer satisfaction Approach 20 quality elements Value adding processes Product requirements Requirements specified by + Statutory & regulatory customer / organization requirements Involvement of What to do, When, Whom & How + Why it is to be done people to do Improvements Maintain the system Continual improvements requirements should be achieved Department of Pharmaceutics 9/2/2012 18
  • 19. Process approach Process definition Set of interrelated or interacting activities which transforms inputs into outputs Identify the Ensure Identify Identify Establish Interaction continual the the Inputs measurin s to other improvemen processes & outputs g criteria processes ts Do it for all value adding processes Department of Pharmaceutics 9/2/2012 19
  • 20. Process approach – Continual improvements of Process Understandings & meeting requirements PLAN Continual improvements Processes in terms of Processes based on Of Added Value PDCA Cycle objective measurements DO ACTION Measure results of process Performance and effectiveness - Objective Measurements CHECK Department of Pharmaceutics 9/2/2012 20
  • 21. System Requirements / Structure of the Standard 4 Quality 5 ISO9000 6 ISO9000 7 ISO9000 8 ISO9000 Manageme structure I structure II structure structure nt System Management Resource III Product IV Responsibility Management Realization Measureme nt Analysis General Management Provision of &improveme Planning requirements Commitment resources nt Customer General Documentation Customer focus Human Requirements resources related processes Monitoring & Quality policy Infrastructures measurement Design & development Control of NCP Planning Work environment Purchasing Analysis of data Responsibility, authority & Production & communication service Improvements provision Management Reviews Department of Pharmaceutics 9/2/2012 21
  • 22. 4 - Quality management system Identification Continual of processes improvements required 4.1 General Criteria and requirements Monitoring and methods to ensure Measuring of Operation & control processes Availability of information & resources for operation & control Department of Pharmaceutics 9/2/2012 22
  • 23. 4 - Quality management system 4.2 Document requirements Quality Policy Quality Objectives Quality Manual Procedures required by the Standard Procedures required for planning, operation & control of Organization activities Records Department of Pharmaceutics 9/2/2012 23
  • 24. 5 - Management Responsibility 5.1 5.2 5.3 5.4 5.6 5.7 Management Customer Quality Planning Responsibility Management commitment focus policy authority & Review communicate Quality Responsibility General objectives & authority Review QMS Management inputs planning representative Review Internal outputs communication Department of Pharmaceutics 9/2/2012 24
  • 25. 5 - Management Responsibility Development, implementation and continually improvement of QMS Establishment of •Quality Policy •Quality Objectives Top Management’s Identification of Customer requirements commitment Communication of importance of •Appointment of Management •Regulatory & statutory requirements Representative •Meeting customer requirements •Conducting Management •Quality Policy & Quality objectives Reviews •Responsibilities & authorities •Providing required resources Department of Pharmaceutics 9/2/2012 25
  • 26. 6 - Resource Management 6.1 6.2 6.3 6.4 Infrastructures Provision of Human Work resources Resources Environment General Competence, awareness & training Department of Pharmaceutics 9/2/2012 26
  • 27. 6 - Resource Management Resources required to Implementing, monitoring & continual improvements Enhance Customer satisfaction by meeting customer requirements Human Resources Resource Managemen t Infrastructures Infrastructures needed to achieve product conformity Work environment Work environment needed to achieve product conformity Department of Pharmaceutics 9/2/2012 27
  • 28. 6 - Human Resources Competent on the basis of appropriate education, skill and experience Define competencies for people performing work affecting product quality 6.2 Human Provide training or actions Resource s Evaluate effectiveness of the training / actions Employees should aware importance of the activity being performed Department of Pharmaceutics 9/2/2012 28
  • 29. 7 - Product Realization 7.1 7.2 7.3 7.4 7.5 7.6 Planning Customer Design and Purchasing Production Control of of product related development & service monitoring processes provision measuring realization devices Identification of Design planning Purchasing Control customer process requirement Design inputs Validation of Purchasing processes Review of Design outputs information customer Identification & requirement traceability Design review Verification of purchased products Customer Design Customer communication verification property Design validation Preservation of product Design Changes Department of Pharmaceutics 9/2/2012 29
  • 30. 7 - Product Realization Quality objectives of Products Processes, procedures to realize product 7.1 Planning of Product Verification, validation, monitoring, ins realization pection and testing of product Record to demonstrate conformance Department of Pharmaceutics 9/2/2012 30
  • 31. 7 - Product Realization Identification of Customer / Market requirements •Specified by customer •Requirements taken for granted 7.2 •Statutory / Regulatory requirements Customer related processes – Review of requirements related (Sales) product prior to acceptance / commitment to customers - ability to meet customer requirements Effective communication with customer in relation to •Product information •Sales order handling •Customer feedback •Customer complaints Department of Pharmaceutics 9/2/2012 31
  • 32. 7 - Product Realization Planning •Effective & efficient •Expectations of interested parties 7.3 Design and Development – (Product) Design inputs and outputs Review and verification, validation and control of changes •Accuracy •Potential hazards & faults •Corrections •Evaluations against lessons learnedPharmaceutics 9/2/2012 Department of 32
  • 33. 7 - Product Realization Degree of control depends on effects of subsequent processes and effect on final product 7.4 Purchasing Supplier evaluation Purchasing is done in controlled manner to ensure that purchased products conforms to specific Verification of purchased product – requirements Inspection and testing Department of Pharmaceutics 9/2/2012 33
  • 34. 7 - Product Realization Product characteristics Procedures and work instructions Suitable equipments to manufacture. 7.5 Monitoring and inspection & testing Production and service provision Product release, delivery and post Manufacturing / delivery service provision under controlled Process validation condition to ensure conformity of product Identification and traceability Customers property Material supplied by customers – e.g.. 3rd party blending Department of Pharmaceutics 9/2/2012 34
  • 35. 8 - Measurement, analysis and improvement 8.1 8.2 8.3 8.4 8.5 Control of General Monitoring & non Analysis Improvement measurements conforming of data product Customer Continual satisfaction improvements Internal audits Corrective action Measurement of processes Preventive action Measurement of product Department of Pharmaceutics 9/2/2012 35
  • 36. 8 - Measurement, analysis and improvement 8.1 - To demonstrate • Conformity of the product • Conformity to QMS requirements • Continually improvements and the effectiveness of the system 8.2 - Monitoring and Measurements •Customer satisfaction / perception •Internal audits - conformity planned arrangements of QMS and ISO9001 •Monitoring and measurements of processes – to determine / demonstrate ability of processes to achieve required results •Monitoring and measurements of product – Conformity to product requirements 8.3 - Control of NCP •To assure that NCP products are identified and controlled to prevent unintended use / delivery Department of Pharmaceutics 9/2/2012 36
  • 37. 8 - Measurement, analysis and improvement 8.4 - Analysis of data Collection and analysis of data generated through QMS activities to verify suitability, effectiveness and continual improvement of the system Analysis shall provide information related to •Customer satisfaction / perception •Conformity to specs, requirements •Trends of processes and products • Opportunities for preventive actions •Suppliers Department of Pharmaceutics 9/2/2012 37
  • 38. 8 - Measurement, analysis and improvement 8.5 - Improvements Continual Improvements •QMS needed to be continually improved Corrective action •Actions to prevent recurrence of NCP, NCR etc •Includes reviews, determination of causes, need of action, implementation of action, review of action and maintenance of relevant records Preventive action •Actions against potential non conformities to avoid their occurrence •Includes identification of potential non conformities, cause, need for action, implementation of action, review of action and maintenance of records Department of Pharmaceutics 9/2/2012 38
  • 39. Criteria for measurements –Satisfaction surveys for customers and other interested parties •Feedback on products •Customer & market requirements –Financial measurements •Prevention cost System •Non conforming / failure cost performanc •Lifecycle cost e Self assessment –Internal audits •Effectiveness & efficiency of processes •Opportunities for improvements •Use of data / information •Effective & efficient use of resources •Adequacy, accuracy and performance of measurements •Relationships with customers/ suppliers/ other interested parties Department of Pharmaceutics 9/2/2012 39
  • 40. Criteria for measurements –Process capability / process validation Processe –Reaction time s –Cycle time / throughput (Capacity) –Utilization of technology –Waste reduction –Cost reduction Products –Inspection and testing of incoming, in process and final product –Product verification –Product validation Department of Pharmaceutics 9/2/2012 40
  • 41. What is ISO 14000? Primarily concerned with Environmental Management Minimize harmful effects on the environment Continual Improvement of environmental performance The formation of ISO Technical Committee 207 (TC 207) in 1993 marks the beginning of the development of the ISO 14000 series. The US Technical Advisory Group (TAG) for ISO/TC 207 (US/TAG for ISO/TC 207) represents the United States in international negotiation on ISO 14000 ISO 14000 ISO 14001 EMS- General Guidelines on EMS- Specification with Principles, Systems and Guidance for Use requires a Supporting Techniques substantial commitment of time and resources Department of Pharmaceutics 9/2/2012 41
  • 42. ISO 14004 ISO 14010 EMS - General Guidelines EA- General Principles of on Systems, Principles and Environmental Auditing Supporting Techniques ISO 14012 ISO 14011 EA- Qualification Criteria for EA- Auditing of Environmental Auditors Environmental Management Systems ISO 14014 Initial Reviews ISO 14013 ISO 14015 Management of Environmental Audit Environmental Site Assessments Programs ISO 14021 ISO 14020 EL- Self Declaration- EL- Basic Principles of Environmental Claims- Terms Environmental Labeling and Definitions Department of Pharmaceutics 9/2/2012 42
  • 43. ISO 14022 EL- Symbols ISO 14024 ISO 14023 EL- Practitioner Programs- EL- Testing and Verification Guiding principles, practices Methodologies and certification procedures of multiple criteria (type1) ISO 14031 ISO 14040 Environmental Performance LCA- General Principles and Evaluation Practices ISO 14041 ISO 14042 LCA- Goal and LCA- Impact Assessment Definition/Scope and ISO 14043 Inventory Assessment LCA- Improvement ISO 14060 Assessment Guide for the Inclusion of ISO 14050 Environmental Aspects in Terms and Definitions Product Standards Department of Pharmaceutics 9/2/2012 43
  • 44. Guides To Pharmaceutical Manufacturing Facilities & Productivity  Quality  Facilities and Equipment  Materials  Production  Packaging/Labeling  Laboratory Controls Department of Pharmaceutics 9/2/2012 44
  • 45. Need of guidelines in pharmaceuticals facilities & productivity  Detailed guidelines of a system so that the findings reflect the state of control in that system for every product (profile) class  If one of the six systems is out of control, the firm is considered out of control  A system is considered out of control based on GMP deficiencies which suggest lack of assurance of quality Department of Pharmaceutics 9/2/2012 45
  • 46. Quality System Quality must be built into the process Quality is not tested into the product Quality System Assurance of Quality comes from - Design of robust process based on thorough knowledge of that process and the sources of variability Effective Quality System in place Department of Pharmaceutics 9/2/2012 46
  • 47. Role of Management in QS  Management is responsible for:  Organizational structure  All Processes  All Procedures  Facilities & Resources  In short, everything to insure product quality, customer satisfaction and continuous improvement Department of Pharmaceutics 9/2/2012 47
  • 48. Quality System Responsibilities  Assures overall compliance 6) Reprocess/ Rework with cGMPs 7) Validation/ Revalidation  Review and approval duties 8) Rejects for: 9) Stability Failures/ Out of 1) Product Quality Reviews (at trend data least annually) 10) Quarantine products 2) Complaint reviews 11) Documented GMP & Job 3) Discrepancy/ failure Related Training investigations 4) Change Control 5) CAPA (Corrective And Preventive Action) Department of Pharmaceutics 9/2/2012 48
  • 49. Laboratory Control System (I) Adequately staffed laboratories (supervisory and bench personnel) Written specifications for raw materials, intermediates, APIs, label Laboratory Control s & packaging System: Written procedures for sampling, testing, approval or rejection of Adequate lab facilities materials and for the recording and under the Quality Unit storage of data which is independent from Production Method validation/ revalidation Validation and Security for computerized handling of test results and related data; system for assuring integrity of all lab data Department of Pharmaceutics 9/2/2012 49
  • 50. Laboratory Control System (II) Reference Standards (primary; secondary) Laboratory controls followed and documented Laboratory Control System Calibration: written procedures, schedule, documentation Equipment Qualification Written procedure (SOP) covering out of specification “oos” results Department of Pharmaceutics 9/2/2012 50
  • 51. Laboratory Control System (III) Investigation of “oos” results conducted in a timely manner as per SOP and documented (complete records maintained). Laboratory Conclusions from “oos” investigations Control documented and corrective actions/ need System for addition investigation identified and implemented. “oos” review included in Product Quality Reviews Description of samples Identification of method used Raw data for sample/ standard preparation, reagents Department of Pharmaceutics 9/2/2012 51
  • 52. Laboratory Control System (IV) Complete record of all data from testing Record of all calculations Statement of the test results; how compare with established acceptance criteria Laboratory Control System Signature of the person who performed each test; dates tests performed Date/ signature of second qualified person who reviewed original test records for accuracy, completeness and compliance with established standards Department of Pharmaceutics 9/2/2012 52
  • 53. Training (documente d; job- related) Implementation and documentation Production of in-process System (I) controls, tests, and examinations Contemporaneous, accura te and complete batch production documentation Department of Pharmaceutics 9/2/2012 53
  • 54. Production system (II) Adequate written procedures & practice for charge-in of materials Identification of equipment with contents, stage of manufacturing, status Equipment cleaning records Established time limits for completion of production steps/ stages Deviations investigated and documented contemporaneously with investigation Department of Pharmaceutics 9/2/2012 54
  • 55. Production system (III) Process validation based on knowledge of process (scientific basis for identifying critical steps/ critical process parameters/control points) Justification and consistency of in-process specifications and final product specifications Data/ information documented and available to Quality Unit for review (trending, investigations etc.) Department of Pharmaceutics 9/2/2012 55
  • 56. Facilities & Equipment System Location, design, construction appropriate to facilitate cleaning, maintenance, operations Layout and air handling designed and constructed to prevent cross- contamination Facilities & Equipment Flow of materials & personnel designed System to prevent mix-ups or contamination Defined areas or other control systems to prevent mix-ups or contamination includes as: Department of Pharmaceutics 9/2/2012 56
  • 57. Facilities & Equipment System Incoming materials (id, quarantine) Sampling area (prevent contamination) Quarantine (intermediates, APIs) Facilities & Released materials Equipment System Rejection b) EQUIPMENTS Appropriate design, size, location, non-reactive product contact surfaces Department of Pharmaceutics 9/2/2012 57
  • 58. Facilities & Equipment System Identification clearly marked Calibration Preventive Maintenance schedule and procedures Facilities & Cleaning procedures and validation Equipment System: b) Records of use, cleaning, maintenance EQUIPMENTS Closed or contained equipment. - Inspection prior to use Separate facilities or containment where needed (penicillin's, highly potent compounds etc.) Department of Pharmaceutics 9/2/2012 58
  • 59. Utilities Qualified and appropriately monitored; drawings should be available Designed and constructed to prevent contamination or cross-contamination Utilities Recirculated air to production (same concern) Permanently installed pipe work should be appropriately identified Drains of adequate size with air break Department of Pharmaceutics 9/2/2012 59
  • 60. Water Process water at minimum meeting WHO guidelines for potable water Justify quality of water used to achieve stated API quality and establish specifications Water Water treatment facilities validation API to be used for incorporation into sterile dosage form – water used in later stages should be monitored and controlled for total microbial counts, objectionable organisms and endotoxins Department of Pharmaceutics 9/2/2012 60
  • 61. Materials System Written procedures for receipt, identification, quarantine, storage, handling, sampling, testing and approval or rejection of materials System to evaluate suppliers (critical materials) Purchased against agreed specification Materials Change control process for System changing suppliers Upon receipt check for correct labeling, seals Before co-mingling bulk material, id/test Assurances obtained from non-dedicated tankers Department of Pharmaceutics 9/2/2012 61
  • 62. Materials System Identification on large storage containers and associated manifolds, filling and discharge lines Code given to received batches; status identity Materials At minimum, a specific identity test System on incoming batches. Supplier evaluation should include three fully tested batches; one fully tested batch/year Written sampling plan with justification Prevent contamination of sampled containers Department of Pharmaceutics 9/2/2012 62
  • 63. Materials System Stored in manner to prevent degradation, contamination, no adverse effect on quality Drums, bags, boxes off the floor Materials System First in, first out Rejected materials identified and controlled under a quarantine system Established re-test/ re-evaluation periods Department of Pharmaceutics 9/2/2012 63
  • 64. Packaging & Labeling System Written procedures for receipt, identification, quarantine, sampling, examination and/or testing P&L P&L should conform to specifications Records maintained for each shipment (showing receipt, examination & result) Containers protective, clean, not alter product quality; if re-used, cleaned & labeling defaced Access to label storage area limited Written procedures for reconciliation; - investigation if discrepancy Department of Pharmaceutics 9/2/2012 64
  • 65. Packaging & Labeling System All excess labels with batch #, destroyed Obsolete labels destroyed Printing devices controlled to insure accuracy of label (against batch record) Print labels checked against master and a copy placed into the batch record Documented procedures to assure correct packaging materials/ labels used Operations designed to prevent mix-ups Department of Pharmaceutics 9/2/2012 65
  • 66. Packaging & Labeling System Labels: API name, batch #, storage conditions Shipped API: Name/ address manufacturer; special transport conditions; expiry/ retest date Documented clearance before operations Packaged/ labeled intermediates or APIs examined as part of packaging (documented) Seal employed to assure package integrity Department of Pharmaceutics 9/2/2012 66
  • 67. Benefits  Certification demonstrates the recognition of quality throughout organization  Decrease in wasted time, materials, and efforts.  Inculcating values of excellence and best practices.  Establish leadership role within organization.  Increased recognition by international partners  Ability to maintain standards of quality and excellence. Department of Pharmaceutics 9/2/2012 67
  • 68. References  Lachman L. Lieberman A. Kanig JL. The Theory Of Industrial Pharmacy, 2nd edi, Varghese Publication House; Bombay-14  Gilbert s. Banker, Christoher T. Rhodes, Modern Pharmaceutics, 3rd edi, New York.  Sharma PP. How To Practice GMPs, 2nd edi, Vandana Publication; Agra.  www.google.com  www.wikipedia.com  www.kwaliteg.co.za.iso:9000.com  www.fda.com Department of Pharmaceutics 9/2/2012 68